Polaris Greystone Financial Group buys $593,326 stake in Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet Holdings Inc (ZBH) : Polaris Greystone Financial Group scooped up 138 additional shares in Zimmer Biomet Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 2, 2016. The investment management firm now holds a total of 4,549 shares of Zimmer Biomet Holdings Inc which is valued at $593,326.Zimmer Biomet Holdings Inc makes up approximately 0.09% of Polaris Greystone Financial Group’s portfolio.

Other Hedge Funds, Including , Parkside Financial Bank Trust reduced its stake in ZBH by selling 348 shares or 26.63% in the most recent quarter. The Hedge Fund company now holds 959 shares of ZBH which is valued at $125,082. Zimmer Biomet Holdings Inc makes up approx 0.06% of Parkside Financial Bank Trust’s portfolio.Sit Investment Associates Inc reduced its stake in ZBH by selling 188,190 shares or 48.74% in the most recent quarter. The Hedge Fund company now holds 197,915 shares of ZBH which is valued at $25,954,573. Zimmer Biomet Holdings Inc makes up approx 0.67% of Sit Investment Associates Inc’s portfolio.First Niagara Bank reduced its stake in ZBH by selling 100 shares or 3.77% in the most recent quarter. The Hedge Fund company now holds 2,554 shares of ZBH which is valued at $313,325. Zimmer Biomet Holdings Inc makes up approx 0.09% of First Niagara Bank’s portfolio.Daiwa Securities Group boosted its stake in ZBH in the latest quarter, The investment management firm added 350 additional shares and now holds a total of 4,750 shares of Zimmer Biomet Holdings Inc which is valued at $582,730.Nordea Investment Management Ab boosted its stake in ZBH in the latest quarter, The investment management firm added 226,480 additional shares and now holds a total of 4,087,633 shares of Zimmer Biomet Holdings Inc which is valued at $517,044,698. Zimmer Biomet Holdings Inc makes up approx 1.47% of Nordea Investment Management Ab’s portfolio.

Zimmer Biomet Holdings Inc opened for trading at $131.24 and hit $131.83 on the upside on Monday, eventually ending the session at $131.66, with a gain of 0.20% or 0.26 points. The heightened volatility saw the trading volume jump to 7,36,789 shares. Company has a market cap of $26,232 M.

On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.97. The company had revenue of $1934.00 million for the quarter, compared to analysts expectations of $1898.18 million. The company’s revenue was up 65.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS.

Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $143 .Company shares were Reiterated by Needham on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 143 from a previous price target of $134 .Zimmer Biomet Holdings Inc was Initiated by Guggenheim to “Neutral” on Jun 9, 2016.

Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.

Leave a Reply

Zimmer Biomet Holdings Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zimmer Biomet Holdings Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.